
zzso is considered a zzso zzso We report 19 cases of significant weight loss associated with zzso at a dose ranging from 500 to 2000 zzso 

The population was divided into two zzso Group 1 includes patients in whom zzso was the only possible cause of weight loss and Group 2 those in whom other factors may have played a zzso Similar cases reported by the French national drug safety center were added zzso zzso 

Group 1 included 9 females and 3 males zzso loss ranging from zzso to zzso Three patients had zzso in zzso Prior zzso only three were zzso One patient was hospitalized for a thorough assessment of weight zzso Seven patients reported reduced caloric intake due to decreased pleasure with zzso The other five did not report any changes in feeding zzso Group 2 included seven females with a weight loss ranging from zzso to zzso One patient was on zzso since two years prior to zzso Weight loss started with the introduction of zzso In 4 patients, there was a decreased dosage or zzso of a previous drug known to produce weight gain in some cases simultaneously to the introduction of zzso but in two of these patients these drugs had not produced any weight zzso Group 3 included only two patients zzso zzso 7 and 20 zzso 

This study provides evidence that zzso can cause significant weight zzso Women are at higher risk while initial weight is not a zzso 

